The primary objective of this non-interventional study is to evaluate efficacy of Symbicort®
SMART treatment in adult patients with moderate to severe asthma using ACQ scores during 6
months period
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
AstraZeneca Romania Clinical Study Information, Phone: +4021 317 60 41, Email: diana.omer@astrazeneca.com
Research Site, Alba Iulia, Romania
Research Site, Alexandria, Romania
Research Site, Arad, Romania
Research Site, Bacau, Romania
Research Site, Baia Mare, Romania
Research Site, Botosani, Romania
Research Site, Braila, Romania
Research Site, Brasov, Romania
Research Site, Breaza, Romania
Research Site, Bucuresti, Romania
Research Site, Buftea, Romania
Research Site, Calarasi, Romania
Research Site, Campina, Romania
Research Site, Campulung, Romania
Research Site, Cluj Napoca, Romania
Research Site, Constanta, Romania
Research Site, Craiova, Romania
Research Site, Deva, Romania
Research Site, Drobeta Turnu Severin, Romania
Research Site, Giurgiu, Romania
Research Site, Hunedoara, Romania
Research Site, Iasi, Romania
Research Site, Leordeni, Romania
Research Site, Miercurea Ciuc, Romania
Research Site, Mizil, Romania
Research Site, Oradea, Romania
Research Site, Palazu Mare, Romania
Research Site, Piatra Neamt, Romania
Research Site, Pitesti, Romania
Research Site, Ploiesti, Romania
Research Site, Resita, Romania
Research Site, Rm. Valcea, Romania
Research Site, Scornicesti, Romania
Research Site, Sf. Gheorghe, Romania
Research Site, Sibiu, Romania
Research Site, Slobozia, Romania
Research Site, Suceava, Romania
Research Site, Targoviste, Romania
Research Site, Targu Mures, Romania
Research Site, Tg. Jiu, Romania
Research Site, Timisoara, Romania
Research Site, Tulcea, Romania
Research Site, Vaslui, Romania
Research Site, Zalau, Romania